 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- LEU-011 / Leucid Bio
Updates on LEU011: An Adaptor CAR Platform () - Apr 19, 2024 - Abstract #IOSUMMITEUROPE2024IO_SUMMIT_EUROPE_89;
Leucid Bio has recently secured regulatory approval to undertake a Phase 1 clinical trial in which LEU011 will be evaluated in patients with a range of NKG2D ligand solid tumours. An update on the LEU011 programme will be provided.
- | LEU-011 / Leucid Bio
New P1/2 trial: AERIAL: LEU01101: Safety and Preliminary Efficacy of LEU011 in Solid Tumours. (clinicaltrials.gov) - Jan 5, 2024
P1/2, N=17, Recruiting, Sponsor: Leucid Bio